NatWest Group plc (LON:NWG)

Intra-Cellular Therapies Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	98,084	101,090	114,258	153,490	186,353	131,526
Investment Securities	130,357	125,906	102,442	72,850	93,738	99,992
Trading Asset Securities	95,216	93,310	91,910	115,034	137,418	206,889
Total Investments	225,573	219,216	194,352	187,884	231,156	306,881
Gross Loans	380,385	370,971	360,328	353,006	339,422	344,285
Allowance for Loan Losses	-3,650	-3,425	-3,645	-3,434	-3,806	-6,186
Other Adjustments to Gross Loans	-	-1,001	-1,025	-889	-891	-1,081
Net Loans	376,735	366,545	355,658	348,683	334,725	337,018
Property, Plant & Equipment	-	3,967	4,227	4,240	4,230	4,418
Goodwill	-	5,675	5,680	5,522	5,522	5,607
Other Intangible Assets	7,513	1,913	1,934	1,594	1,201	1,048
Accrued Interest Receivable	-	-	-	327	248	216
Other Receivables	-	7	49	279	190	192
Restricted Cash	-	3,755	4,566	4,959	4,353	7,673
Other Current Assets	6,335	-	-	7,438	9,600	600
Long-Term Deferred Tax Assets	-	1,876	1,894	2,178	1,195	901
Other Long-Term Assets	16,538	3,941	10,055	3,459	3,219	3,411
Total Assets	730,778	707,985	692,673	720,053	781,992	799,491
Accrued Expenses	-	1,353	1,411	1,407	1,508	990
Interest Bearing Deposits	473,916	453,424	440,885	460,534	484,204	441,504
Total Deposits	473,916	453,424	440,885	460,534	484,204	441,504
Short-Term Borrowings	66,971	96,678	97,678	110,994	132,441	179,596
Current Portion of Long-Term Debt	-	12,464	10,047	8,711	7,829	5,066
Current Portion of Leases	-	94	102	137	238	185
Current Income Taxes Payable	-	263	332	55	12	63
Other Current Liabilities	71,678	49,728	55,231	48,227	47,004	53,509
Long-Term Debt	71,946	41,681	38,155	39,934	40,205	42,657
Long-Term Leases	563	536	568	981	1,025	1,513
Long-Term Unearned Revenue	-	394	402	355	319	361
Pension & Post-Retirement Benefits	-	80	99	98	114	121
Long-Term Deferred Tax Liabilities	-	99	141	227	359	291
Other Long-Term Liabilities	3,728	11,813	10,434	11,897	24,931	29,811
Total Liabilities	688,802	668,607	655,485	683,557	740,189	755,667
Preferred Stock, Non-Redeemable	-	0.5	0.5	0.5	0.5	1
Preferred Stock, Other	-	-	-	-	493.5	493
Total Preferred Equity	-	0.5	0.5	0.5	494	494
Common Stock	10,133	8,972	9,683	10,539	11,468	12,129
Additional Paid-In Capital	-	1,161	1,161	1,161	667	617
Retained Earnings	12,679	11,426	10,645	10,019	12,966	12,567
Treasury Stock	-747	-868	-503	-258	-371	-24
Comprehensive Income & Other	19,893	18,659	16,171	15,027	16,572	18,077
Total Common Equity	41,958	39,350	37,157	36,488	41,302	43,366
Minority Interest	18	28	31	8	7	-36
Shareholders' Equity	41,976	39,378	37,188	36,496	41,803	43,824
Total Liabilities & Equity	730,778	707,985	692,673	720,053	781,992	799,491
Total Debt	139,480	151,453	146,550	160,757	181,738	229,017
Net Cash (Debt)	112,385	104,920	110,429	149,053	188,926	153,966
Net Cash Growth	-3.02%	-4.99%	-25.91%	-21.11%	22.71%	40.33%
Net Cash Per Share	13.67	12.32	11.98	15.01	17.43	13.71
Filing Date Shares Outstanding	8,088	8,043	8,793	9,659	10,467	11,248
Total Common Shares Outstanding	8,088	8,043	8,793	9,659	10,467	11,248
Book Value Per Share	4.44	4.24	3.78	3.37	3.57	3.41
Tangible Book Value	34,445	31,762	29,543	29,372	34,579	36,711
Tangible Book Value Per Share	3.51	3.29	2.92	2.64	2.93	2.82

Source: S&P Global Market Intelligence. Banks template. Financial Sources.